mfresearch ๐Ÿ”’ Show amounts

Axis Multicap Fund - Direct Plan - Growth Option

code 149383 Multi Cap Fund direct plan ยท growth NAVs 2021-12-23 to 2026-11-09

Benchmark: NIFTY 500 MULTICAP 50:25:25 official TRI declared: AMFI Fund Performance (Fund-Performance-30-Sep-2026--2031 (2).xlsx), as of 2026-09-30 Compare with:

Growth of โ‚น10,000 vs benchmark

From 2021-12-23, common dates. Scroll or drag to zoom.

Drawdown

Rolling 3-year CAGR

Returns

periodfundfund*benchmark*fund โˆ’ benchmark*from โ†’ to
1M5.54% -3.87%-5.78% 1.92% 2026-10-09 โ†’ 2026-11-09
3M2.79% 4.09%-2.81% 6.89% 2026-08-07 โ†’ 2026-11-09
6M11.32% 18.14%9.00% 9.15% 2026-05-08 โ†’ 2026-11-09
1Y11.89% 9.55%0.55% 9.00% 2025-11-07 โ†’ 2026-11-09
3Y19.66% 18.77%10.97% 7.79% 2023-11-09 โ†’ 2026-11-09
5Y- -- -
7Y- -- -
10Y- -- -
since inception16.77% 16.07%11.73% 4.35% 2021-12-23 โ†’ 2026-11-09

Absolute under 1 year, CAGR from 1 year. * Common dates only.

Calendar years

year2022202320242025
fund-0.20%38.31%33.81%2.42%
benchmark2.84%33.74%19.34%5.29%

Rolling returns

lengthperiodsaveragemedianworstbest% positive% beating benchmark
1 year92421.31%15.20% -4.22%59.34%93% 87%
3 years43522.69%22.68% 17.15%29.59%100% 100%

Risk and risk-adjusted return

3 years
2023-11 โ€“ 2026-10
CAGR18.83%
volatility16.27%
max drawdown-18.08%
downside deviation10.59%
Sharpe ratio0.79
Sortino ratio1.20
Calmar ratio1.04
alpha (annualised)-
beta-
Rยฒ-
tracking error-
information ratio-
up / down capture-
Treynor ratio-
36 months: benchmark lacks some months of the window: no relative metrics

Category: Multi Cap Fund

Overall โ˜…โ˜…โ˜…โ˜…โ˜… (3y โ˜…โ˜…โ˜…โ˜…โ˜… ยท 5y - ยท 10y -) ยท as of 2026-10 ยท 58 months of history

percentile rank (1 = best)3 years
of 23 funds
return1st
volatility37th
Sharpe1st
Sortino1st
worst fall14th
risk-adjusted return (MRAR)1st

View category โ†’

Ratings: Morningstar method. Differences: risk-free rate: RBI 91-day T-bill (Morningstar uses FBIL MIBOR Overnight for rupee funds); peer groups: SEBI-category groups (D13), not Morningstar Categories; no analyst rating suspensions.

Add to comparison โ†’